![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 22, 16408-16413, June 2, 2000
,
¶
From the
Howard Hughes Medical Institute and
Department of Biochemistry, Baylor College of Medicine,
Houston, Texas 77030 and § New England Biolabs, Inc.,
Beverly, Massachusetts 01915
Received for publication, January 11, 2000, and in revised form, February 4, 2000
| |
ABSTRACT |
|---|
|
|
|---|
PI-SceI is a member of a class of proteins
(inteins) that excise themselves from a precursor protein and in the
process ligate the flanking protein sequences (exteins). We report here
the 2.1-Å resolution crystal structure of a PI-SceI miniprecursor
(VMA29) containing 10 N-terminal extein residues and 4 C-terminal
extein residues. Mutations at the N- and C-terminal splicing junctions, blocking in vivo protein splicing, allowed the
miniprecursor to be purified and crystallized. The structure reveals
both the N- and C-terminal scissile peptide bonds to be in distorted
trans conformations ( Posttranslational autoprocessing involving peptide bond
rearrangement has been observed in a variety of different systems including protein splicing, autoprocessing of hedgehog proteins, autocleavage of amidohydrolase, and pyruvoyl enzyme formation (1).
Protein splicing element was first discovered in the
VMA1 gene of
Saccharomyces cerevisiae (2). The chemical mechanism of
protein splicing has been extensively studied (3-7). Protein splicing
begins with an acyl rearrangement at the N-terminal junction whereby
the conserved Ser or Cys attacks the carbonyl carbon of the preceding
residue forming an ester or thioester intermediate (Fig.
1a). The conserved Cys/Ser/Thr
residue at the C-terminal splicing site attacks the ester/thioester
intermediate resulting in the formation of the branched intermediate.
The next step couples the cyclization of a conserved Asn adjacent to
the C-terminal splicing junction with the cleavage of the peptide bond
to the branched ester (thioester) intermediate. The excised intein
containing an aminosuccinimide residue at the C terminus and the
ligated N- and C-terminal exteins are formed. Finally, a spontaneous O
100°). Modeling of the
wild-type PI-SceI based on the VMA29 structure indicates a large
conformational change (movement of >9 Å) must occur to allow
transesterification to be completed. A zinc atom was discovered at the
C-terminal splicing junction. Residues Cys455,
His453, and Glu80 along with a water molecule
(Wat53) chelate the zinc atom. The crystal structure of
VMA29 has captured the intein in its pre-spliced state.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
N/S
N acyl rearrangement of the branched ester linkage
completes the splicing event.

View larger version (20K):
[in a new window]
Fig. 1.
a, schematic diagram of the chemical
mechanism for protein splicing. The four-step reaction couples the
excision of the intein (red) from the precursor protein with
the ligation of the two exteins (blue and
blue-green) via a native peptide bond. b, diagram
of the new motif structure of PI-SceI according to Pietrokovski (9).
Blocks N1-N4 and C1 and C2
(blue) contain residues involved in protein splicing; blocks
EN1-EN4 (black) contain residues associated with
the endonuclease/linker domain. Nucleophilic residues are
highlighted below the block diagram (yellow
letters in purple box), and highly conserved residues
are shown in red. c, sequence alignment of the wild-type
PI-SceI (VMA) and mutant miniprecursor (VMA29).
The red dash and arrow illustrate the N- and
C-terminal splicing sites. Red residues in the VMA29
sequence indicate mutations made to the wild-type sequence
(blue). Cys1 and Asn454 were mutated
to Ala in order to block in vivo protein splicing.
Currently, over 100 protein splicing elements, inteins, have been deposited into the New England Biolabs Intein Data base (8). The primary amino acid sequence of the inteins can be divided into three conserved domains, N-terminal, C-terminal, and an optional endonuclease (9). The N-terminal domain is subdivided into four motifs, N1-N4. Likewise the C-terminal and endonuclease domains are divided into two and four motifs, C1 and C2 and EN1-EN4, respectively (Fig. 1b). The splicing motifs are located in blocks N1-N4, and C1 and C2 with strictly conserved residues (His79 and Asn454) residing in blocks N3 and C1, respectively. The penultimate histidine of PI-SceI is highly conserved (>90% of the inteins contain this amino acid) but is not essential for splicing of the PI-SceI intein (3, 10, 11). Asn454 and Cys455, however, are absolutely necessary for protein splicing (3, 10, 11).
Crystal structures exist for two of these inteins, PI-SceI homing
endonuclease (12) and GyrA splicing domain (13) as well as two
mechanistically related proteins, hedgehog autoprocessing domain (14)
and glycosylasparaginase (15). The four structures all exhibit the
-scaffold termed the HINT (Hedgehog, INTein) module (14). The GyrA
structure contains a single Ala0 preceding the mutated
Cys1
Ser1 of the intein. The peptide
linkage between Ala0 and Ser1 is in the
energetically less favorable cis conformation with the
hydroxyl group of Ser1 positioned for a nucleophilic attack
on the carbonyl carbon of Ala0 (13). The structure suggests
Thr72, His75, and His197 play
catalytic roles in the splicing reaction.
Glycosylasparaginase activates itself by an N
O acyl shift followed
by hydrolysis of the ester linkage (15). As a result, the N-terminal
side of a loop covering the active site is cleaved to allow the
substrate to enter. In contrast to the GyrA structure, the structure of
glycosylasparaginase has revealed a high energy distorted
trans peptide at the N-terminal junction (15). Residues involved in the N
O acyl rearrangement (Asp151 and
Thr152) form an unusual tight turn that forces the scissile
peptide bond from an
= 180° (planar conformation) to an
<160°. Along with the main chain dihedral angle distortion, the
angle of Asp151 deviates ~9° from the ideal 110°. The
authors conclude that these main chain distortions around the cleavage
site could raise the energy 5 kcal/mol for each distorted residue.
The crystal structures of GyrA and glycosylasparaginase give
structural support to the proposed splicing mechanism. However, the
former lacks a full complement of residues from the N- and C-exteins
including the absolutely required Thr199 at the C-terminal
splicing junction. The latter structure seems applicable only to the
initial acyl rearrangement step in the protein splicing pathway. In the
current study, we have cloned and expressed a mutant of the VMA1 intein
(identified as VMA29) in which Cys1 and Asn454
have been mutated to Ala in order to block protein splicing. In
addition, 10 residues (MKAEEGKLEG) have been added to the N terminus of
the intein as well as four residues (CGER) to the C terminus (Fig.
1c). This structure is the first example of a true precursor
of an intein.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Protein Expression and Purification--
Plasmid pVMA29 encoding
the VMA mutant C1A/N454A (VMA29) with the sequence MKAEEGKLEG
positioned upstream to the N-terminal cleavage site and the sequence
CGER positioned downstream to the C-terminal splicing site was used to
transform the Escherichia coli strain B834(DE3), a
methionine auxotroph. Cells containing the pVMA29 were grown in
LeMaster media to an A600 = 0.5, induced with
0.5 mM
isopropyl-1-thio-
-D-galactopyranoside, and grown for an
additional 15 h at 20 °C. Cells were lysed by the addition of
20 mg of lysozyme to cells suspended in 50 mM NaCl, 20 mM HEPES, pH 7.0. After 30 min incubation at 20 °C, the
sample was pulse-sonicated for 3 min. The lysate was clarified by
centrifugation at 18,000 rpm for 30 min in a Beckman J25 centrifuge.
Clarified lysate was filtered through a 0.22-µm filter and loaded
directly onto a Porus Heparin column. Samples containing the 50-kDa
VMA29 protein were eluted from the column with a gradient run from 50 mM NaCl to 1 M NaCl. These fractions were
pooled and concentrated, and the buffer was exchanged to 50 mM NaCl, 20 mM HEPES, pH 7.0. Pooled fractions
were loaded onto Source 15S column from Amersham Pharmacia Biotech and
eluted with 50 mM to 1 M NaCl gradient.
Fractions containing VMA29, as determined by SDS-polyacrylamide gel
electrophoresis, were pooled and loaded on to an S200 gel filtration
column equilibrated with 500 mM NaCl, 20 mM
HEPES, pH 7.0. SDS-polyacrylamide gel electrophoresis was used to
locate the fractions containing the mutant protein; these fractions
were pooled, concentrated, and the buffer exchanged to 500 mM NaCl, 20 mM HEPES, pH 7.0. Light-scattering experiments performed on these samples (data not shown) indicated the
protein sample was monodispersed with an apparent molecular mass of 115 kDa.
Crystallization and Data Collection--
VMA29 was crystallized
using the hanging drop vapor diffusion method. Crystals were grown from
droplets containing 2 µl (31 mg/ml) of protein and 2 µl of
polyethylene glycol 3350 (10% w/v, 3 mM CdCl2,
1 mM MgCl2, 10 mM
-mercaptoethanol, 100 mM Tris-HCl, pH 8.5). The
resulting 4-µl droplet was equilibrated against a well containing 500 µl of the above polyethylene glycol solution. The crystals belong to
the space group P21 (unit cell a = 59.00 Å, b = 101.68 Å, c = 86.77 Å,
= 93.51o) and contain two molecules in the
asymmetric unit. Crystals (0.3 mm in each direction) were stabilized in
a mother liquor containing 25% glycerol, flash-cooled to
170 °C
in liquid nitrogen, and used for data collection. A 2.0-Å data set was
collected at the HHMI X4A beam line of the National Synchrotron Light
Source (NSLS), and data were reduced using DENZO and SCALEPACK (16).
The synchrotron data encompassed 180o of reciprocal space
and were >95% complete (see Table
I).
|
Structure Determination and Refinement-- Data collected on the VMA29 mutant were completely isomorphous with the previously determined structure of PI-SceI. Model phases for the VMA29 mutant were calculated based on the refined crystal structure of PI-SceI (12) (Protein Data Bank code 1VDE) with the water molecules removed. XTALVIEW (17) was used to examine the initial electron density map which showed a rough fit of the model to the experimental data with strong density present at the N and C terminus corresponding to the additional sequence present in the miniprecursor mutant. Refinement was carried out employing the simulated annealing protocol in the crystallographic and NMR system (18) software package, followed by a 30-step individual Bfactor refinement.
The N- and C-terminal addition sequences as well as water
molecules were built into the electron density map based on Fourier coefficients (|Fobs|
|Fcalc|)ei
calc. Water
molecules were placed in difference electron density peaks only if the
peaks were above 2.5
and if acceptable hydrogen bonds to atoms in
the model could be made. Deletion of water molecules occurred if the
water molecules refined position was farther than 3.3 Å from its
nearest neighbor or if their Bfactors exceeded 70 Å2. The statistics for the current refined structure are
summarized in Table I.
Zinc Determination--
Zn2+ concentration was
determined using Perkin-Elmer 2380 atomic absorption spectrometer in
the laboratory of Dr. D. Giedroc at Texas A&M University. A standard
curve from 0.5 µM Zn+2 to 6.0 µM Zn2+ was used to quantitate the
concentration of zinc in the protein sample. The protein solution was
diluted. The atomic absorption readings from 1:50, 1:100, and 1:200
dilutions of the protein solution were averaged to give a mean zinc
concentration of 161 µM. Using the molar extinction
coefficient of 4.68 × 104/mol for
VMA29,2 the protein
concentration was determined to be 123 µM. The zinc present in the protein sample co-purified with the protein since neither the protein storage buffer (50 mM NaCl, 20 mM HEPES, pH 7.0) nor the crystallization solution
described above contained any measurable zinc.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Structure of the N-terminal Splicing Junction--
The refined
crystal structure of VMA29 consists of two independent molecules (A and
B) in the asymmetric unit. The VMA29 molecule from residues 1 to 454 (the intein) has a fold identical to the PI-SceI intein (12). Of the 10 additional residues at the N terminus of VMA29, the last 4 (Lys
4, Leu
3, Glu
2, and
Gly
1) have well defined electron density in molecule B
(Fig. 2). Leu
3,
Glu
2, and Gly
1 have been shown to support
proficient splicing (3). The side chain of Glu
2 forms a
hydrogen bond to the backbone amide of Leu
3, which fixes
the main chain atoms of Lys
4 and Leu
3. The
amide nitrogen of Gly
1 hydrogen bonds to the carbonyl
oxygen of Ile434, and its carbonyl oxygen is
hydrogen-bonded to the amide of the same residue. The backbone amide of
Glu
2 and the side chain of Leu
3 are in van
der Waal contact with S-
from Cys455. The C-
2 atom of
Leu
3 packs against the nonpolar side chain atoms of
Glu457. The arrangement of hydrogen bonds around
Gly
1 and the packing of the
2 and
3 residues against
residues 455 and 457 distort the main chain geometry of
Gly
1. Its
angle (N-C
-C) measures 100°, 10°
less than the ideal angle. The scissile peptide bond between
Gly
1 and Ala1 is in the trans
conformation, in agreement with the structure of glycosylasparaginase,
but contrary to the GyrA structure (13). The Sce VMA intein seems more
tolerant at the
1 position (19) than some mini-inteins (20-22). The
mutational evidence provides support for the possibility of a distorted
trans conformation to exist in the full-length Sce VMA
precursor.
|
Molecule A in the asymmetric unit differs from B in that only residues
Glu
2 and Gly
1 are defined by strong
electron density. The main chain distortion observed in the molecule B
is reduced here (
angle of 105°), and the scissile peptide bond is
also in the trans conformation. A
50° rotation about the
1 torsion angle (C
1-C'1) will
superimpose Ala1 from molecule A onto B. In the A molecule,
Gly
1 has no hydrogen bond interaction with other
surrounding residues. The backbone NH and carbonyl oxygen of Ala 1 make
hydrogen bonds with the O-
1 and NH, respectively, of
Asn76. Glu
2 contributes to the structural
stability of this area with a hydrogen bond between its carbonyl oxygen
and the side chain hydroxyl of Thr78.
Structure of the C-terminal Splicing Junction--
The four native
extein residues (Cys455, Gly456,
Glu457, and Arg458) at the C-terminal splicing
junction of molecule B are clearly defined by electron density (Fig.
2). However, in molecule A, electron density defines only
Cys455. The most notable feature at the C-terminal splicing
site is the unexpected presence of a zinc atom in both molecules,
chelated by Glu80, the highly conserved His453,
Cys455, and a water molecule. The geometry of zinc
coordination in molecule B is T4 (tetrahedral) (23) (Fig.
3) with all three center angles involving
the zinc atom measuring ~110°. It is unclear whether the zinc
binding is structural or catalytic; however, the coordinating angles
and bond distances are closer to those characteristic of a structural
zinc (23). The zinc-binding site in the molecule A exhibits elongated
electron density consistent with at least two different zinc binding
modes. One involves His442, Cys455, and
His453 (
2 =
61), and a water molecule,
whereas the other is similar to the site in the B molecule. Atomic
absorption spectrometry identified the presence of one zinc atom per
protein molecule (see "Materials and Methods"), but we found no
measurable zinc in the storage or crystallization buffers. From these
data, we conclude that the zinc atom co-purified with the VMA29
protein.
|
Residues that chelate the zinc atom are important for protein splicing
in the wild-type VMA protein. Cys455 receives the
N-terminal extein during the transesterification reaction resulting in
the formation of the branched intermediate (3). His453 is
highly conserved among inteins deposited into the New England Biolabs
intein data base (~90% of the inteins contain a histidine at this
position). It is also adjacent to Asn454 (an Ala in the
current structure) which is absolutely conserved and essential for
excising the spliced exteins from the intein (3, 6). Glu80
is not a conserved residue, but it is adjacent to the strictly conserved, catalytically required, His79 (24) which is
hydrogen-bonded to the amide of the scissile peptide bond at the
N-terminal splice junction (or at Gly
1).
His42 is a conserved residue in motif C2. The main chain
distortion found in Gly
1 (
= 100°) is also
present in Ala454. The chelation of the zinc atom by
His453 and Cys455 bends the main chain at this
residue (Fig. 3) thereby causing the observed change in
angle
resulting in increase in energy of the peptide bonds surrounding this
residue. In the wild-type protein, Asn454 undergoes
succinimide formation whereby its side chain cyclizes with its own
backbone carbonyl carbon. The distortion at this residue could help
lower the energy barrier for succinimide formation. We conclude
Cys455, His453, and Asn454 are
poised to receive the thioester formed at Cys1 and undergo
transesterification and succinimide formation.
Model of Wild-type VMA Intein--
The wild-type model of the VMA
precursor was generated by replacing Ala1 and
Ala454 in the VMA29 structure with Cys and Asn,
respectively, and energy-minimizing the structure (see "Materials and
Methods"). Side chain atoms were modeled such that their
corresponding
1 angles were equal to the most favored,
Cys
1 =
60 and Asn
1 =
180. Following energy minimization, these angles undergo only very slight changes (
61° and
177°, respectively). The S-
atom of the modeled
Cys1 is in position to hydrogen bond to the side chain
O-
1 of Asn76 and is also within 4.4 Å of its own
carbonyl carbon. The O-
atom of Asn454 is 3.5 Å from
Thr435 backbone amide, and its N-
atom is 2.7 Å from
both Thr435 backbone carbonyl oxygen and its own backbone
carbonyl carbon. The model reveals a hydrophobic surface to the
"back" of Asn454 (away from the N-terminal splicing
junction) comprised of side chain atoms from Ile434,
Phe444, Leu436, Val37, and
Val27. This surface constrains the
1 values
between
117° and
180° (i.e. in an orientation
consistent with cyclization). The distance between the S-
atom of
Cys1 and the same atom of Cys455 is ~9 Å in
both molecules in the asymmetric unit. It is unclear how this distance
is traversed during transesterification.
Comparison of VMA29 and GyrA Structures--
The model for GyrA
(Protein Data Bank code 1AM2 (13)) precursor was superimposed onto the
structure of the VMA29 precursor (Fig.
4a) using the sequence
alignment (HINT module) found in Klabunde et al. (13). Fig.
4b illustrates residues involved in protein splicing occupy
the same relative position in each protein even though VMA29 contains a
bound zinc atom and residues comprising the N- and C-terminal exteins.
The largest deviation in
-carbon position, 1.46 Å, occurs between
GyrA Ser1 and VMA29 Ala1. The catalytically
required GyrA His75 is 1.22 Å from the position of its
equivalent residue in VMA29 (His79). Likewise the conserved
His197 is 1.05 Å from the position of VMA29
His453; however, the side chain
2 differs by
136° (
78 and 58, respectively). Similarly, Thr72 and
Asn76 are within 1.03 Å of each other, and the strictly
conserved Asn198 and Ala454 are 1.30 Å from
one another. The structural superposition illustrates zinc binding at
the C-terminal splicing junction does not influence the relative
positions of the amino acids proven to be involved in protein splicing.
It does, however, influence the side chain orientation of the
penultimate histidine. The additional N- and C-extein residues also do
not appear to perturb the important splicing residues. The Sce VMA
inteins with Leu
3, Glu
2,
Gly
1, Cys455, and Gly456 have
previously been shown to undergo efficient splicing (6). Thus, this is
a splicing relevant structure.
|
VMA29 Structure and Protein Splicing--
Based on the wild-type
model for the VMA precursor, we propose the following molecular
mechanism (Fig. 5). The side chain carbonyl oxygen of Asn76 and the S-
of Cys1
are within hydrogen bonding distance (2.91 Å). This interaction would
help polarize the sulfhydryl such that its lone pair electrons would be
oriented toward the carbonyl carbon of scissile peptide bond. Much like
the GyrA structure (13), there does not appear to be a good general
base in close proximity to Cys1. Glu
2 is
within 3.5 Å of S-
atom, but the amino acid at this position has
not been shown to be critical for protein splicing (3). It is not clear
from this structure how the thiolate anion is generated. Regardless of
the exact mechanism responsible for sulfhydryl activation, a
tetrahedral intermediate would be formed during the acyl shift
reaction. The intermediate could be stabilized by interactions of N-
from Asn76 and O-
from Thr78 (Fig.
5a). The imidazole ring of His79 is in position
to protonate the amide nitrogen of Cys1 promoting the break
down of the tetrahedral intermediate to form the thioester. Relieving
the distorted/strained main chain atoms of Gly
1 may help
drive the N
S acyl rearrangement.
|
The transesterification reaction requires the thioester between
Gly
1 and Cys1 to be in close proximity to the
acceptor, Cys455. As stated above, the distance between the
modeled side chain of Cys1 and that of Cys455
is ~9 Å (Fig. 5b). It is not possible at this time to
determine exactly how this gap is traversed, but the tight type II turn between residues 3 and 6 could relax and allow Cys1 to move
toward Cys455. His453
Gln substitution
provides experimental evidence for a conformational change occurring
during splicing of the PI-SceI intein. C-terminal cleavage in the
resulting mutant was shown to be absolutely dependent on N-terminal
cleavage to liberate the N terminus (19).
The coordination between Cys455 and the zinc atom would be
disrupted when the thioester is presented. The zinc atom could move away from the newly formed thioester and take up a position between His454 and His442 (much like the position
observed in molecule A of this structure) or it could diffuse away from
the protein (Fig. 5c). If the former occurred, a main chain
carbonyl oxygen from either Gly456 or Asn454
could replace the sulfur atom from Cys455 in the
coordination of the zinc. His453 would then rotate
~120° about
2 to orient its N-
toward the new position of
zinc and in doing so would position its N-
such that it could donate
a proton to the amide nitrogen of Cys455 after asparagine
cyclization. The resulting orientation of His453 would be
consistent with that observed in the GyrA structure as well as the side
chain orientation found in one of the zinc binding modes of molecule A.
Experimental data suggest that succinimide formation could occur
independently of the initial steps in the splicing reaction. Self-splicing inteins carrying mutations of Cys1 inhibited
cleavage at the N-terminal splice junction but still retained cleavage
activity at the C-terminal splice junction (11, 20, 21). However, in
the normal splicing pathway prior cleavage at the N-terminal junction
would be favored to occur before asparagine cyclization coupled peptide
bond cleavage could proceed. Since transesterification most likely
involves the relaxation of the type II tight turn between residues 3 and 6, subsequently the residues involved in cyclization of
Asn454 would take favorable positions (Fig. 5d).
His453 would be in position to protonate the amino group of
Cys455. The side chain nitrogen of Asn454
refined to a position where it hydrogen bonds to the carbonyl oxygen of
Ile434. These interactions coupled with the hydrophobic
surface orient the
-amide such that it could attack its own backbone
carbonyl carbon. As a result the amide bond between Asn454
and Cys455 would be broken down forming the C-terminal
aminosuccinimide which would be hydrolyzed to form a C-terminal
asparagine or isoasparagine. A spontaneous S
N acyl shift would
result in a stable amide bond between Gly
1 and
Cys455, thus completing protein splicing.
The VMA29 miniprecursor structure presented here provides the first
image of a true intein precursor containing multiple residues from both
N- and C-terminal exteins. The N-terminal scissile peptide bond is in
the trans conformation with a distorted
angle in the
1
residue. These observations are in agreement with the recently solved
crystal structure of glycosylasparaginase (15) but contradict the
findings of Klabunde et al. (13) concerning GyrA. An
unexpected finding is a bound zinc atom chelated by residues located at
the C-terminal splicing junction. We propose a splicing mechanism consistent with experimental evidence in which the PI-SceI intein may
utilize a structural zinc atom.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Z. Wang, G. Hu, and C. Ogata for assistance with data collection at Brookhaven National Laboratory facility; F. Feng and M. Scott for technical assistance; Dr. D. Giedroc for assistance with zinc determination; and D. Comb for support and encouragement.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and structure factors (code 1EF0) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org).
¶ To whom correspondence should be addressed: Howard Hughes Medical Inst., Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Tel.: 713-798-6565; E-mail: faq@bcm.tmc.edu.
2 F. S. Gimble, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: VMA, vacuolar membrane ATPase; HINT, hedgehog intein; VMA29, PI-SceI miniprecursor; VMA1, PI-SceI intein from the vacuolar ATPase subunit of S. cerevisiae; C-extein, intein C-terminal flanking region; N-extein, intein N-terminal region.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Paulus, H. (1998) Chem. Soc. Rev. 27, 375-386[CrossRef] |
| 2. |
Kane, P. M.,
Yamashiro, C. T.,
Wolczyk, D. F.,
Neff, N.,
Goebl, M.,
and Stevens, T. H.
(1990)
Science
250,
651-657 |
| 3. |
Chong, S.,
Shao, Y.,
Paulus, H.,
Benner, J.,
Perler, J. B.,
and Xu, M.-Q.
(1996)
J. Biol. Chem.
271,
22159-22168 |
| 4. | Xu, M.-Q., and Perler, F. B. (1996) EMBO J. 15, 5146-5153[Medline] [Order article via Infotrieve] |
| 5. | Shao, Y., Xu, M.-Q., and Paulus, H. (1996) Biochemistry 35, 3810-3815[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Xu, M.-Q., Comb, D. G., Paulus, H., Noren, C. J., Shao, Y., and Perler, F. B. (1994) EMBO J. 13, 5517-5522[Medline] [Order article via Infotrieve] |
| 7. | Kawasaki, M., Makino, S.-I., Matsuzawa, H., Satow, Y., Ohya, Y., and Anraku, Y. (1996) Biochem. Biophys. Res. Commun. 222, 827-832[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Perler, F. B.,
Davis, E. O.,
Dean, G. E.,
Gimble, F. S.,
Jack, W. E.,
Neff, N.,
Noren, C. J.,
Thorner, J.,
and Belfort, M.
(1994)
Nucleic Acids Res.
22,
1125-1127 |
| 9. | Pietrokovski, S. (1998) Protein Sci. 7, 64-71[Abstract] |
| 10. | Hirata, R., and Anraku, Y. (1993) Biochem. Biophys. Res. Commun. 188, 40-47 |
| 11. | Cooper, A. A., Chen, Y., Lindorfer, M. A., and Stevens, T. H. (1993) EMBO J. 12, 2575-2583[Medline] [Order article via Infotrieve] |
| 12. | Duan, X., Gimble, F. S., and Quiocho, F. A. (1997) Cell 89, 555-564[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Klabunde, T., Sharma, S., Telenti, A., Jacobs, W. R., and Sacchettini, J. C. (1998) Nat. Struct. Biol. 5, 31-36[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Hall, T. M., Porter, J. A., Young, K. E., Koonin, E. V., Beachy, P. A., and Leahy, D. J. (1997) Cell 91, 85-97[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Xu, Q., Buckley, D., Guan, C., and Gou, H.-C. (1999) Cell 98, 651-661[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326 |
| 17. | McRee, D. E. (1992) J. Mol. Graph. 10, 44-47[CrossRef] |
| 18. | Brünger, A. T., Adams, P. D., Clore, G. M., Gros, P., Grosse-Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Cryst. Sect. D Biol. Crystallogr. 54, 905-921[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Chong, S.,
Williams, K. S.,
Wotkowicz, C.,
and Xu, M.-Q.
(1998)
J. Biol. Chem.
273,
10567-10577 |
| 20. |
Evans, T. C. J.,
Benner, J.,
and Xu, M.-Q.
(1999)
J. Biol. Chem.
274,
3923-3926 |
| 21. | Mathys, S., Evans, T. C. J., Chute, I. C., Wu, H., Chong, S., Benner, J., Liu, X.-Q., and Xu, M.-Q. (1999) Gene (Amst.) 231, 1-13[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Southworth, M. W., Amaya, K., Evans, T. C., Xu, M.-Q., and Perler, F. B. (1999) BioTechniques 27, 110-120[Medline] [Order article via Infotrieve] |
| 23. | Alberts, I. L., Nadassy, K., and Wodak, S. J. (1998) Protein Sci. 7, 1700-1716[Abstract] |
| 24. |
Perler, F. B.,
Olsen, G. J.,
and Adam, E.
(1997)
Nucleic Acids Res.
25,
1087-1093 |
| 25. | Merrit, E. A., and Bacon, D. J. (1997) Methods Enzymol. 277, 505-524[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
K. Michalska, A. Hernandez-Santoyo, and M. Jaskolski The Mechanism of Autocatalytic Activation of Plant-type L-Asparaginases J. Biol. Chem., May 9, 2008; 283(19): 13388 - 13397. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun and H.-C. Guo Structural constraints on autoprocessing of the human nucleoporin Nup98 Protein Sci., March 1, 2008; 17(3): 494 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Prieto, J.-C. Epinat, P. Redondo, E. Ramos, D. Padro, F. Cedrone, G. Montoya, F. Paques, and F. J. Blanco Generation and Analysis of Mesophilic Variants of the Thermostable Archaeal I-DmoI Homing Endonuclease J. Biol. Chem., February 15, 2008; 283(7): 4364 - 4374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Johnson, M. W. Southworth, T. Herrmann, L. Brace, F. B. Perler, and K. Wuthrich NMR structure of a KlbA intein precursor from Methanococcus jannaschii Protein Sci., July 1, 2007; 16(7): 1316 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Prieto, P. Redondo, D. Padro, S. Arnould, J.-C. Epinat, F. Paques, F. J. Blanco, and G. Montoya The C-terminal loop of the homing endonuclease I-CreI is essential for site recognition, DNA binding and cleavage Nucleic Acids Res., May 11, 2007; 35(10): 3262 - 3271. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shemella, B. Pereira, Y. Zhang, P. Van Roey, G. Belfort, S. Garde, and S. K. Nayak Mechanism for Intein C-Terminal Cleavage: A Proposal from Quantum Mechanical Calculations Biophys. J., February 1, 2007; 92(3): 847 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sun, J. Yang, and X.-Q. Liu Synthetic Two-piece and Three-piece Split Inteins for Protein trans-Splicing J. Biol. Chem., August 20, 2004; 279(34): 35281 - 35286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Romanelli, A. Shekhtman, D. Cowburn, and T. W. Muir Semisynthesis of a segmental isotopically labeled protein splicing precursor: NMR evidence for an unusual peptide bond at the N-extein-intein junction PNAS, April 27, 2004; 101(17): 6397 - 6402. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ding, M.-Q. Xu, I. Ghosh, X. Chen, S. Ferrandon, G. Lesage, and Z. Rao Crystal Structure of a Mini-intein Reveals a Conserved Catalytic Module Involved in Side Chain Cyclization of Asparagine during Protein Splicing J. Biol. Chem., October 3, 2003; 278(40): 39133 - 39142. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Epinat, S. Arnould, P. Chames, P. Rochaix, D. Desfontaines, C. Puzin, A. Patin, A. Zanghellini, F. Paques, and E. Lacroix A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells Nucleic Acids Res., June 1, 2003; 31(11): 2952 - 2962. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and H.-C. Guo Two-step Dimerization for Autoproteolysis to Activate Glycosylasparaginase J. Biol. Chem., January 24, 2003; 278(5): 3210 - 3219. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Werner, W. Wende, A. Pingoud, and U. Heinemann High resolution crystal structure of domain I of the Saccharomyces cerevisiae homing endonuclease PI-SceI Nucleic Acids Res., September 15, 2002; 30(18): 3962 - 3971. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Perler InBase: the Intein Database Nucleic Acids Res., January 1, 2002; 30(1): 383 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ghosh, L. Sun, and M.-Q. Xu Zinc Inhibition of Protein trans-Splicing and Identification of Regions Essential for Splicing and Association of a Split Intein* J. Biol. Chem., June 22, 2001; 276(26): 24051 - 24058. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Mills and H. Paulus Reversible Inhibition of Protein Splicing by Zinc Ion J. Biol. Chem., March 30, 2001; 276(14): 10832 - 10838. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||